Sarepta Therap

Forecast & Rating24 analysts currently cover Sarepta Therap, with about 33.3% giving a positive rating — meaning they expect the stock to rise. The average price target is $22.09, about 11.9% upside from the current price of $19.73. Price targets range from $5.00 to $38.00 — a wide spread, showing clear disagreement over just how much Sarepta Therap can rise. Historically, about 63.2% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Sarepta Therap's outlook. Data as of Aug 13, 2026; for reference only and not investment advice.